Insight to InvitroCue’s Success - from Invention to IPO

Insight to InvitroCue’s Success - from Invention to IPO

On Jan 27 2016, local biotech company InvitroCue made its debut on the Australian Securities Exchange (ASX: IVQ) - just four years after its founding. The company, a spin-off from A*STAR, just announced that it had raised an AUD 3.15 Million (SGD3.17 Million) on the ASX through a reverse takeover.

Read More

Biotech Connection Singapore (BCS) and ETPL MOU Press Release

BCS high res logo-1.png

Biotech Connection Singapore has signed a Memorandum of Understanding with ETPL, the commercialisation arm of the Agency for Science, Technology and Research (A*STAR). Together, they share a vision of building an eco-system for biotech entrepreneurs in Singapore that will inspire disruptive enterprises.

The biotech eco-system in Singapore is advancing at a fast pace. This partnership between BCS and ETPL creates a much-needed platform through which budding entrepreneurs and academic scientists can mingle and exchange ideas freely, adding color and vibrancy to the biotech entrepreneurship landscape in Singapore.As part of this partnership, Biotech Connection Singapore and ETPL will actively co-organize events, workshops and networking sessions on various topics that will be of great interest to all biotech entrepreneurs-to-be. Through this partnership, Biotech Connection Singapore and ETPL hope to equip would-be entrepreneurs with the knowledge to innovate and crystalize their ideas into real world solutions that will translate into successful enterprises.


About Biotech Connection Singapore

Biotech Connection Singapore is part of an international network of non-profit organizations that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses. We aim to connect innovators with each other and industry resources to help you get the support necessary to conceptualize, develop and commercialize technology & research. Our engagement with the community occurs via three ways: education, consulting and communications.

About ETPL

ETPL is the commercialisation arm of the Agency for Science, Technology and Research (A*STAR), Singapore’s lead agency for fostering world-class scientific research and talent. As a one-stop resource, ETPL supports A*STAR in transforming the economy through driving innovation and commercialising its research outcomes.

Also known as Exploit Technologies Pte Ltd, ETPL enhances the research output of A*STAR scientists by translating their inventions and intellectual capital into marketable products, processes and services. Through shaping and facilitating licensing deals and spin-offs, ETPL actively engages industry leaders and players to commercialise A*STAR’s technologies and apply them to building ecosystems that benefit business, industry and economy.

For more information, please visit

Download PDF